GLPGF (Lakefront Biotherapeutics NV) Tariff Resilience Score: 8/10 (As of Jun. 25, 2026)


GLPGF Lakefront Biotherapeutics NV GLPGF
62 GF Score
Price $28.08
GF Value $136.98
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Lakefront Biotherapeutics NV Tariff Resilience Score?

Lakefront Biotherapeutics NV GLPGF 62 Tariff Resilience Score is 8 as of Jun. 25, 2026. GuruFocus rates GLPGF with a GF Score™ of 62/100 and a GF Value™ of $136.98 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,379 Biotechnology companies, Lakefront Biotherapeutics NV ranks better than 98.69% on this metric.

Lakefront Biotherapeutics NV has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Lakefront Biotherapeutics NV has Galapagos NV, a biotech firm, is less exposed to tariffs due to its focus on R&D and pharmaceuticals, which typically face fewer trade barriers. Its partnerships and licensing agreements further reduce tariff vulnerability.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Lakefront Biotherapeutics NV might have Highly Resilient.

Lakefront Biotherapeutics NV  (OTCPK:GLPGF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Lakefront Biotherapeutics NV Tariff Resilience Score Related Terms

GLPGF vs VRTX, REGN, ALNY: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Lakefront Biotherapeutics NV's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lakefront Biotherapeutics NV Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lakefront Biotherapeutics NV's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Lakefront Biotherapeutics NV's Tariff Resilience Score falls into.


GLPGF
62GF Score
Lakefront Biotherapeutics NV GLPGF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Lakefront Biotherapeutics NV (GLPGF) has a Tariff Resilience Score of 8 as of Jun. 25, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Lakefront Biotherapeutics NV ranks #18 out of 1379 companies in the Biotechnology industry, placing it in the top 1.3%.
Is Lakefront Biotherapeutics NV's Tariff Resilience Score too high?
Lakefront Biotherapeutics NV's current Tariff Resilience Score is 8. The Biotechnology industry median Tariff Resilience Score is 4.00. Lakefront Biotherapeutics NV's value of 8 is 100% above this industry median. Based on the distribution chart, Lakefront Biotherapeutics NV ranks #18 out of 1379 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Lakefront Biotherapeutics NV has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lakefront Biotherapeutics NV's Tariff Resilience Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Lakefront Biotherapeutics NV ranks #18 out of 1379 companies for Tariff Resilience Score. This places Lakefront Biotherapeutics NV in the top 1% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Lakefront Biotherapeutics NV's value of 8 is 100% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,379 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lakefront Biotherapeutics NV's current Tariff Resilience Score of 8 is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lakefront Biotherapeutics NV's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lakefront Biotherapeutics NV stock overvalued right now?
Based on GuruFocus' analysis, Lakefront Biotherapeutics NV (GLPGF) is currently considered Possible Value Trap. The stock's GF Value™ is $136.98, compared to a current price of $28.08 — trading 79.5% below its estimated fair value. The current Tariff Resilience Score is 8 and 100% above the Biotechnology industry median of 4.00. Lakefront Biotherapeutics NV's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Lakefront Biotherapeutics NV (GLPGF), the current Tariff Resilience Score is 8 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lakefront Biotherapeutics NV (GLPGF) Overvalued in 2026?

Based on GuruFocus' analysis, Lakefront Biotherapeutics NV stock appears to be undervalued. The current stock price of $28.08 is trading 79.5% below its estimated GF Value™ of $136.98. GuruFocus considers Lakefront Biotherapeutics NV to be Possible Value Trap.

Key valuation signals for GLPGF:

  • Tariff Resilience Score: 8
  • GF Value™: $136.98 vs. price of $28.08 (79.5% below fair value)
  • GF Score™: 62/100 with 4 warning signs
  • Industry Position: 100% above the Biotechnology median (#18 of 1379)

No single metric tells the full story. See the GLPGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lakefront Biotherapeutics NV Business Description

Address Schalienhoevedreef 20 T, Mechelen, BEL, 2800
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
62GF Score

Get the complete analysis for GLPGF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.08
Price
$136.98
GF Value